Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs SpaceX (SPCX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs SpaceX — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B), while SpaceX trades at $166.42 (market cap $2.27T). The key difference: SpaceX is far larger — about 1327.5× Nuvation Bio Inc. Class A Common Stock's market cap, and SpaceX is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and SpaceX for 41 Days on average.
| NUVB | SPCX | |
|---|---|---|
Market Cap | $1.71B | $2.27T |
Volume | 5,448,712 | 76,951,787 |
Sector | Health | Industrials |
52-Week High | $9.54 | $202.09 |
52-Week Low | $3.41 | $108.27 |
Typical Hold Time | 0 Days | 41 Days |
Enterprise Value | $1.30B | $2.21T |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About SpaceX
SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.
Read more on SPCX →
